| Dr Candis Nicole Bell, MD | |
|
1381 N Wayne St, Angola, IN 46703-2348 | |
| (260) 665-8222 | |
| (260) 665-8970 |
| Full Name | Dr Candis Nicole Bell |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 12 Years |
| Location | 1381 N Wayne St, Angola, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013275767 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD24953 (Maine) | Secondary |
| 207Q00000X | Family Medicine | 010845521A (Indiana) | Secondary |
| 207Q00000X | Family Medicine | 036157739 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Harrisburg Medical Center | Harrisburg, IL | Hospital |
| Southern Illinois Hospital Services Dba Herrin Hospital | Herrin, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Midwest Inpatient Anderson Health Inc | 3072908474 | 40 |
| Trinity Medical Staffing Llc | 1759712698 | 27 |
News Archive
Celldex Therapeutics, Inc. today announced positive results demonstrating promising clinical effects in a Phase 1 study of CDX-1401 in solid tumors in combination with the toll-like receptor (TLR) agonists resiquimod and/or Poly ICLC.
A National Cheng Kung University (NCKU) research team has discovered that a protein called interleukin (IL)-20 is a key to treating osteoporosis, a disease that lowers a person's bone density.
A tale of two sisters has helped researchers solve a medical mystery and discover a familial genetic mutation that causes an inherited form of the lung disease Pulmonary Alveolar Proteinosis (PAP).
UCB announced today that the U.S. Food and Drug Administration has approved Cimzia (certolizumab pegol) for the treatment of adults with active ankylosing spondylitis.
› Verified 6 days ago
| Entity Name | Crawford Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861423287 PECOS PAC ID: 7719898071 Enrollment ID: O20040205000950 |
News Archive
Celldex Therapeutics, Inc. today announced positive results demonstrating promising clinical effects in a Phase 1 study of CDX-1401 in solid tumors in combination with the toll-like receptor (TLR) agonists resiquimod and/or Poly ICLC.
A National Cheng Kung University (NCKU) research team has discovered that a protein called interleukin (IL)-20 is a key to treating osteoporosis, a disease that lowers a person's bone density.
A tale of two sisters has helped researchers solve a medical mystery and discover a familial genetic mutation that causes an inherited form of the lung disease Pulmonary Alveolar Proteinosis (PAP).
UCB announced today that the U.S. Food and Drug Administration has approved Cimzia (certolizumab pegol) for the treatment of adults with active ankylosing spondylitis.
› Verified 6 days ago
| Entity Name | Illinois Hospitalists Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871832931 PECOS PAC ID: 8224275862 Enrollment ID: O20130520000092 |
News Archive
Celldex Therapeutics, Inc. today announced positive results demonstrating promising clinical effects in a Phase 1 study of CDX-1401 in solid tumors in combination with the toll-like receptor (TLR) agonists resiquimod and/or Poly ICLC.
A National Cheng Kung University (NCKU) research team has discovered that a protein called interleukin (IL)-20 is a key to treating osteoporosis, a disease that lowers a person's bone density.
A tale of two sisters has helped researchers solve a medical mystery and discover a familial genetic mutation that causes an inherited form of the lung disease Pulmonary Alveolar Proteinosis (PAP).
UCB announced today that the U.S. Food and Drug Administration has approved Cimzia (certolizumab pegol) for the treatment of adults with active ankylosing spondylitis.
› Verified 6 days ago
| Entity Name | Trinity Medical Staffing Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770103426 PECOS PAC ID: 1759712698 Enrollment ID: O20200511000598 |
News Archive
Celldex Therapeutics, Inc. today announced positive results demonstrating promising clinical effects in a Phase 1 study of CDX-1401 in solid tumors in combination with the toll-like receptor (TLR) agonists resiquimod and/or Poly ICLC.
A National Cheng Kung University (NCKU) research team has discovered that a protein called interleukin (IL)-20 is a key to treating osteoporosis, a disease that lowers a person's bone density.
A tale of two sisters has helped researchers solve a medical mystery and discover a familial genetic mutation that causes an inherited form of the lung disease Pulmonary Alveolar Proteinosis (PAP).
UCB announced today that the U.S. Food and Drug Administration has approved Cimzia (certolizumab pegol) for the treatment of adults with active ankylosing spondylitis.
› Verified 6 days ago
| Entity Name | Midwest Emergency Anderson Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710647615 PECOS PAC ID: 8022401256 Enrollment ID: O20220210000357 |
News Archive
Celldex Therapeutics, Inc. today announced positive results demonstrating promising clinical effects in a Phase 1 study of CDX-1401 in solid tumors in combination with the toll-like receptor (TLR) agonists resiquimod and/or Poly ICLC.
A National Cheng Kung University (NCKU) research team has discovered that a protein called interleukin (IL)-20 is a key to treating osteoporosis, a disease that lowers a person's bone density.
A tale of two sisters has helped researchers solve a medical mystery and discover a familial genetic mutation that causes an inherited form of the lung disease Pulmonary Alveolar Proteinosis (PAP).
UCB announced today that the U.S. Food and Drug Administration has approved Cimzia (certolizumab pegol) for the treatment of adults with active ankylosing spondylitis.
› Verified 6 days ago
| Entity Name | Midwest Inpatient Anderson Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821758608 PECOS PAC ID: 3072908474 Enrollment ID: O20220322002045 |
News Archive
Celldex Therapeutics, Inc. today announced positive results demonstrating promising clinical effects in a Phase 1 study of CDX-1401 in solid tumors in combination with the toll-like receptor (TLR) agonists resiquimod and/or Poly ICLC.
A National Cheng Kung University (NCKU) research team has discovered that a protein called interleukin (IL)-20 is a key to treating osteoporosis, a disease that lowers a person's bone density.
A tale of two sisters has helped researchers solve a medical mystery and discover a familial genetic mutation that causes an inherited form of the lung disease Pulmonary Alveolar Proteinosis (PAP).
UCB announced today that the U.S. Food and Drug Administration has approved Cimzia (certolizumab pegol) for the treatment of adults with active ankylosing spondylitis.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Candis Nicole Bell, MD Po Box 468, Skowhegan, ME 04976-0468 Ph: (207) 474-5121 | Dr Candis Nicole Bell, MD 1381 N Wayne St, Angola, IN 46703-2348 Ph: (260) 665-8222 |
News Archive
Celldex Therapeutics, Inc. today announced positive results demonstrating promising clinical effects in a Phase 1 study of CDX-1401 in solid tumors in combination with the toll-like receptor (TLR) agonists resiquimod and/or Poly ICLC.
A National Cheng Kung University (NCKU) research team has discovered that a protein called interleukin (IL)-20 is a key to treating osteoporosis, a disease that lowers a person's bone density.
A tale of two sisters has helped researchers solve a medical mystery and discover a familial genetic mutation that causes an inherited form of the lung disease Pulmonary Alveolar Proteinosis (PAP).
UCB announced today that the U.S. Food and Drug Administration has approved Cimzia (certolizumab pegol) for the treatment of adults with active ankylosing spondylitis.
› Verified 6 days ago
Larry E Watkins, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 301 E Maumee St Ste 201, Angola, IN 46703 Phone: 260-665-2164 Fax: 260-665-3932 | |
Dr. Jonathan E Alley, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 424 Williams St, Angola, IN 46703 Phone: 260-665-5170 Fax: 260-665-6979 | |
Berry L Miller, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 306 E Maumee St Ste 201, Angola, IN 46703 Phone: 260-667-2700 Fax: 260-667-2611 | |
Dr. Terry L Shipe, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 306 E Maumee St Ste 201, Angola, IN 46703 Phone: 260-665-7595 Fax: 260-665-6586 | |
Dr. Jacqueline Leigh Akey, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 306 E Maumee St Ste 303, Angola, IN 46703 Phone: 260-665-8494 Fax: 260-667-5564 | |
Dr. Taarif Hussain, M.D. FAAFP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 416 E Maumee St, Angola, IN 46703 Phone: 260-498-2020 |